Is usual measurement of blood pressure meaningful?

Blood Pressure Monitoring

Volumn 4, Issue 2, 1999, Pages 71-76

  Campbell, Norm R C ^a   Myers, Martin G ^b   McKay, Donald W ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Blood pressure; Blood pressure measurement; Hypertension

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STANDARDIZATION; SYSTOLIC BLOOD PRESSURE;

EID: 0032849776     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-199902000-00003     Document Type: Article

References (68)

1. 1 The Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Ottawa: Health Canada; 1994. pp. 1-1009.
2. 2 Schappert SM, National ambulatory medical care survey. 1991 summary. Vital health stat 13. Hyattsville, MD: National Centre for Health Statistics. 1994.
3. 3 Rutan G, Kuller LH, Neaton JD, Wentworth DN, McDonald RH, Smith WM. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation 1988; 77:504-514.
4. 4 Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 1967; 202:116-122.
5. 5 Hulley SB, Furborg CD, Gurland B, et al. Systolic hypertension in the elderly program (SHEP): antihypertensive efficacy of chlorthalidone. Am J Cardiol 1985; 56:913-920.
6. 6 Hypertension Detection and Follow-Up Program Cooperative Group. The Hypertension Detection and Follow-Up Program. A progress report. Circ Res 1977; 40:1106-1109.
7. 7 Hypertension Detection and Follow-Up Program Cooperative Group. Five year findings of the hypertension detection and follow-up program. JAMA 1979; 242:2562-2571.
8. 8 Hypertension Detection and Follow-Up Program Cooperative Group. Five year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. JAMA 1982; 247:633-638.
9. 9 Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial. JAMA 1982; 248:1465-1476.
10. 10 The IPPPSH Collaborative Group. Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH). J Hypertens 1985; 3:379-392.
11. 11 Myers MG, Oh PI, Reeves RA, Joyner CD. Prevalence of white coat effect in treated hypertensive patients in the community. Am J Hypertens 1995; 8:591-597.
12. 12 Hypertension Detection and Follow-Up Program Cooperative Group. The effect of treatment on mortality in 'mild' hypertension. N Engl J Med 1982; 307:976-980.
13. 13 Wikstrand J, Warnold I, Tuomilehto J, Olsson G, Barber HJ, Eliasson K, et al. Metropolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study. Hypertension 1991; 17:579-588.
14. 14 USA Public Health Service Hospitals Cooperative Study Group, Smith WM. Treatment of mild hypertension: results of a ten-year intervention trial. Circ Res 1977; 40:198-1105.
15. 15 Dahlof B, Hansson L, Lindholm LH, Rastam L, Schersten B, Wester PO. STOP-Hypertension: Swedish Trial in Old Patients with Hypertension. J Hypertens 1986; 4:511-513.
16. 16 European Working Party on High Blood Pressure in the Elderly (EWPHE). An international trial of antihypertensive therapy in elderly patients. Objectives, protocol and organization. Arch Int Pharmacodyn 1985; 275:300-334.
17. 17 Grimm RH, Cohen JD, Smith WM, Falvo-Gerard L, Neaton JD, Multiple Risk Factor Intervention Trial Research Group. Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Arch Intern Med 1985; 145:1191-1198.
18. 18 Amery A, Birkenhager W, Bulpitt CJ, Clement D, De Leeuw P, Fagard R, et al. Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging 1991; 3:287-302.
19. 19 Amery A, Brixko P, Clement D, Schaepdryver AD, Fagard R, Forte J, et al/. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985; 1:1349-1354.
20. 20 Veterans Administration Cooperative Study Group on Antihypertensive Agents. A double blind control study of antihypertensive agents. Arch Intern Med 1960; 106:133-148.
21. 21 Management Committee. The Australian therapeutic trial in mild hypertension. Lancet 1980; 1261-1267.
22. 22 Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338:1281-1285.
23. 23 Coope J. A trial of treatment of hypertension in the elderly in general practice. Acta Med Scand 1982; 676:141-150.
24. 24 Perry HM, Goldman AI, Lavin MA, Schnaper HW, Fitz AE, Frohlich ED, et al. Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Ann NY Acad Sci 1978; 304:267-297.
25. 25 Coope J, Warrender TJ. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ 1986; 293:1145-1148.
26. 26 he Oslo Study. Treatment of mild hypertension: a five year controlled drug trial. Am J Med 1980; 69:725-732.
27. 27 Carter AB. Hypotensive therapy in stroke survivors. Lancet 1970; 486-489.
28. 28 Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970; 213:1143-1152
29. 29 Barraclough M, Joy MD, MacGregor GA, Baintin D, Cochrane AL, Greene J, et al. Report of a co-operative randomized controlled trial. Control of moderately raised blood pressure. BMJ 1973; 434-436.
30. 30 Kuramato K, Matushita S, Kuwajima I, Murakami M. Prospective study on the treatment of mild hypertension in the aged. Jap Heart J 1981; 22:75-85.
31. 31 Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350:757-764.
32. 32 Wikstrand J, Westergren G, Berglund G, Bracchetti D, Couter AV, Feldstein CA, et al. Antihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60 to 75 years. JAMA 1986; 255:1304-1315.
33. 33 Systolic Hypertension in the Elderly Program (SHEP). Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265:3255-3302.
34. 34 Medical Research Council Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304:405-412.
35. 35 Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985; 291:97-104.
36. 36 Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al. Treatment of mild hypertension study. Final results. JAMA 1993; 270:713-724
37. 37 McKay DW, Campbell NR, Parab LS, Chockalingam A, Fodor JG. Clinical assessment of blood pressure. J Hum Hypertens 1990; 4:639-645.
38. 38 McKay DW, Raju MK, Campbell NR. Assessment of blood pressure measuring techniques. Med Educ 1992; 26:208-212.
39. 39 Bowman CE. Blood pressure errors with aneroid sphygmomanometers [letter]. Lancet 1981;i:1005.
40. 40 Burke MJ, Towers HM, O'Malley K, Fitzgerald DJ, O'Brien ET. Sphygmomanometers in hospital and family practice: problems and recommendations. BMJ 1982; 285:469-471.
41. 41 Conceicao S, Ward WK, Kerr DNS. Defects in sphygmomanometers: an important source of error in blood pressure recording. BMJ 1976; 1:886-888.
42. 42 Perlman LV, Chiang BN, Keller J, Blackburn H. Accuracy of sphygmomanometers in hospital practice. Arch Int Med 1970; 125:1000-1003.
43. 43 Shaw A, Deehan C, Lenihan JMA. Sphygmomanometers: errors due to blocked vents. BMJ 1979; 1:789-790.
44. 44 Scherwitz LW, Evans LA, Hennrikus DJ, Vallbona C. Procedures and discrepancies of blood pressure measurements in two community health centers. Med Care 1982; 20:727-738.
45. 45 Patterson HR, Sources of error in recording the blood pressure of patients with hypertension in general practice. BMJ 1984; 289:1661-1664.
46. 46 Grim CM, Grim CE. Blood pressure measurement. In: Anonymous: The AHA hypertension primer. Dallas: American Heart Association; 1993. pp. 217-220.
47. 47 Grim CM, Grim CE. Teaching and assessing blood pressure measurement skills for medical students [abstract]. Am J Hypertens 1995; 8:79A.
48. 48 Perry IJ, Wilkinson LS, Shinton RA, Beevers DG. Conflicting views on the measurement of blood pressure in pregnancy. Br J Obstet Gynaecol 1991; 90:241-243.
49. 49 Villegas I, Arias IC, Botero A, Escobar A. Evaluation of the technique used by health-care workers for taking blood pressure. Hypertension 1995; 26:1204-1206.
50. 50 Dickson RC, Birkett NJ. Blood pressure measurement by family physicians. Can Family Physician 1988; 34:275-278.
51. 51 Krass ME, LaBarber LP, Torres M. Blood pressure measurement in family physician offices. Family Med 1988; 20:25-27.
52. 52 Bogan B, Kritzer S, Deane D. Nursing student compliance to standards for blood pressure measurement. J Nursing Educ 1993; 32:90-92.
53. 53 Gleichmann SI, Gleichmann UM, Mannebach HJ, Mellwig K-P, Philippi H-H. Educating nurses in blood pressure measurement and hypertension control. J Hypertens 1989; 7 (suppl 3):S99-S102.
54. 54 Campbell NRC, Chockalingam A, Fodor JG, McKay DW. Errors in assessment of blood pressure. Patient factors. Can J Public Health 1994; 85(suppl2):12s-17s.
55. 55 Campbell NR, Hogan DB, McKay DW. Pitfalls to avoid in the measurement of blood pressure in the elderly. Can J Public Health 1994; 85 (suppl 2):26s-28s.
56. 56 Campbell NRC, Chockalingam A, Fodor JG, McKay DW, Errors in assessment of blood pressure. Blood pressure measuring technique. Can J Public Health 1994; 85 (suppl 2):18s-21s.
57. 57 Campbell NR, McKay DW, Chockalingam A, Fodor JG. Errors in assessment of blood pressure: sphygmomanometers and blood pressure cuffs. Can J Public Health 1994; 85 (suppl 2);22s-25s.
58. 58 Myers MG, Oh PI, Reeves RA, Joyner CD. Prevalence of white coat effect in treated hypertensive patients in the community. Am J Hypertens 1995; 8:591-597.
59. 59 Fagard R, Staessen JA, Thijs L, Amery A. Multiple standardized clinic blood pressures may predict left ventricular mass as well as ambulatory monitoring. Am J Hypertens 1995; 8:533-540.
60. 60 Fagard R, Staessen JA, Thijs L. Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension 1997; 39:22-29.
61. 61 Evans CE, Logan AG. The Canadian consensus on hypertension management. Montréal: Canadian Hypertension Society; 1990.
62. 62 Devereaux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55:613-618.
63. 63 Dans AL, Dans LF, Guyatt Gordon H, Richardson S. Users' guides to the medical literature. XIV. How to decide on the applicability of clinical trial results to your patient. JAMA 1998; 279:545-549.
64. 64 Medical Technology and Practice Patterson Institute. Hypertension: questions of prevalence, diagnosis, and management. J Clin Hypertens 1987; 3:757-767.
65. 65 Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med 1978; 299:741-744.
66. 66 Smith GT. The economics of hypertension. Am Heart J 1990; 119:725-728.
67. 67 Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827-838.
68. 68 Moser M, Hebert P, Honnekens CH. An overview of the meta-analyses of the hypertension treatment trials. Arch Intern Med 1991, 151:1277-1279.